In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days

Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function

(2010) Ana M. Galan et al.   TRANSFUSION

In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology

(2010) Sisse R. Ostrowski et al.   TRANSFUSION

p38 mitogen-activated protein kinase activation during platelet storage: consequences for platelet recovery and hemostatic function in vivo

(2009) M. Canault et al.   BLOOD

Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies

(2009) Susanne M. Picker et al.   TRANSFUSION

Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study

(2009) Susanne M. Picker et al.   TRANSFUSION AND APHERESIS SCIENCE

Pathogen reduction technology (Mirasol®) treated single-donor platelets resuspended in a mixture of autologous plasma and PAS

(2009) K. Janetzko et al.   VOX SANGUINIS

Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction

(2009) S. M. Picker et al.   VOX SANGUINIS

Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units

(2008) Susanne M. Picker et al.   TRANSFUSION

Comparison of a novel viscous platelet additive solution and plasma: preparation and in vitro storage parameters of buffy-coat-derived platelet concentrates

(2008) J. G. Zhang et al.   VOX SANGUINIS